# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2171-2180 of 2218 results.
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy
Status: Recruiting
Last Changed: Feb 21, 2020
First Received: Jan 13, 2020
Disease(s): Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
Intervention(s): CT-RD06
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang, China
A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
Status: Active, not recruiting
Last Changed: Jun 23, 2020
First Received: Oct 20, 2014
Disease(s): Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma
Intervention(s): TGR-1202, Ibrutinib
Locations: Pacific Cancer Care, Monterey, California, United States
St. Francis Hospital and Cancer Center, Hartford, Connecticut, United States
Eastern Maine Medical Center/ Northern Light Cancer Care, Brewer, Maine, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States
... and 2 other locations.
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
Status: Completed
Last Changed: Aug 21, 2013
First Received: May 21, 2003
Disease(s): Leukemia, Lymphoma
Intervention(s): filgrastim, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, methotrexate, vincristine sulfate
Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
University of South Alabama Medical Center, Mobile, Alabama, United States
MBCCOP - Gulf Coast, Mobile, Alabama, United States
Arizona Cancer Center, Tucson, Arizona, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
... and 115 other locations.
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Status: Completed
Last Changed: Jul 25, 2014
First Received: Sep 06, 2004
Disease(s): Leukemia, Lymphoma
Intervention(s): filgrastim, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, methotrexate, vincristine sulfate
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
Children's Memorial Hospital, Chicago, Chicago, Illinois, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
... and 10 other locations.
Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies
Status: Recruiting
Last Changed: Sep 11, 2020
First Received: Sep 14, 2018
Disease(s): Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Intervention(s): TG-1701, Umbralisib, Ublituximab
Locations: TG Therapeutics Investigational Trial Site, Adelaide, Australia
TG Therapeutics Investigational Trial Site, Fitzroy, Australia
St. Vincent's Hospital, Melbourne, Australia
TG Therapeutics Investigational Trial Site, Nedlands, Australia
TG Therapeutics Investigational Trial Site, Kraków, Poland
... and 4 other locations.
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
Status: Unknown status
Last Changed: Aug 02, 2012
First Received: Apr 04, 2012
Disease(s): Non-Hodgkin Lymphoma by Clinical Course
Intervention(s): Bendamustine
Locations: Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Status: Completed
Last Changed: Mar 13, 2015
First Received: Mar 19, 2009
Disease(s): Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma
Intervention(s): bendamustine and lenalidomide, BL-NHL, BLR-CLL, BLR-NHL
Locations: Georgetown University Hospital/Lombardi Cancer Center, Washington, District of Columbia, United States
Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Dec 23, 2016
First Received: Jun 07, 2006
Disease(s): Lymphoma
Intervention(s): rituximab, bortezomib, yttrium Y 90 ibritumomab tiuxetan, Indium 111 ibritumomab tiuxetan
Locations: Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Status: Completed
Last Changed: Jul 13, 2016
First Received: May 03, 2004
Disease(s): Lymphoma
Intervention(s): rituximab
Locations: CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
CCOP - Carle Cancer Center, Urbana, Illinois, United States
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
... and 17 other locations.
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Status: Completed
Last Changed: May 29, 2018
First Received: Jul 20, 2007
Disease(s): Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Intervention(s): hLL1
Locations: Weill Cornell Medical College, New York, New York, United States